Timothy A. Lin

The University of Texas MD Anderson Cancer Center

MathematicsEconomics, Econometrics and FinanceDecision SciencesMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Assessment of Median and Mean Survival Time in Cancer Clinical Trials”.

Assessment of Median and Mean Survival Time in Cancer Clinical Trials

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.6498

N/A

0.449DataRank · unranked

19 citations

Timothy A. Lin, Christine Lin, Tomer Meirson, Zachary R. McCaw, Lü Tian +2 more

Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy

European Journal of Cancer(2023)10.1016/j.ejca.2023.113357

N/A

0.449DataRank · unranked

19 citations

Pavlos Msaouel, Zachary R. McCaw, Joseph Abi Jaoude, Eric J. Hsu, Ramez Kouzy +13 more

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae028

N/A

0.360DataRank · unranked

10 citations

Timothy A. Lin, Dor Reuven Dabush, Zachary R. McCaw, Alex Koong, Christine Lin +19 more

Professional Medical Writer Assistance in Oncology Clinical Trials

The Oncologist(2020)10.1634/theoncologist.2020-0406

N/A

0.330DataRank · unranked

8 citations

Joseph Abi Jaoude, W. Ian P. Mainwaring, Timothy A. Lin, Austin B. Miller, Amit Jethanandani +8 more

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

Cancers(2020)10.3390/cancers12092636

N/A

0.292DataRank · unranked

6 citations

Clifton D. Fuller, Vivek Verma, W. Ian P. Mainwaring, Andres F. Espinoza, Austin B. Miller +10 more

Food and Drug Administration approvals in phase 3 Cancer clinical trials

BMC Cancer(2021)10.1186/s12885-021-08457-5

N/A

0DataRank · unranked

27 citations

Ramez Kouzy, Marc Ghabach, Roshal R. Patel, Dario Pasalic, Elie Ghossain +9 more

Detecting the Dark Matter of Unpublished Clinical Cancer Studies

Mayo Clinic Proceedings(2021)10.1016/j.mayocp.2020.08.015

N/A

0DataRank · unranked

10 citations

Clifton D. Fuller, W. Ian P. Mainwaring, Timothy A. Lin, Austin B. Miller, Amit Jethanandani +11 more

Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.13819

N/A

0DataRank · unranked

12 citations

Joseph Abi Jaoude, Roshal R. Patel, Ramez Kouzy, Timothy A. Lin, Brian De +11 more

Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials

BMJ Oncology(2024)10.1136/bmjonc-2024-000322

N/A

0DataRank · unranked

19 citations

Pavlos Msaouel, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, Esther J. Beck +9 more

Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0566

N/A

0DataRank · unranked

13 citations

Zachary R. McCaw, Alex Koong, Christine Lin, Joseph Abi Jaoude, Roshal R. Patel +14 more

Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.05.033

N/A

0DataRank · unranked

3 citations

Timothy A. Lin, Zachary R. McCaw, Esther J. Beck, Ramez Kouzy, Joseph Abi Jaoude +10 more

Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae318

N/A

0DataRank · unranked

2 citations

Alexander D. Sherry, Andrew Arifin, Gabrielle S. Kupferman, Ramez Kouzy, Joseph Abi Jaoude +8 more

Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials

The Oncologist(2024)10.1093/oncolo/oyae067

N/A

0DataRank · unranked

1 citations

Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, Cullen M. Taniguchi +4 more

Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials

medRxiv(2024)10.1101/2024.07.23.24310891

N/A

0DataRank · unranked

3 citations

Pavlos Msaouel, Gabrielle S. Kupferman, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy +12 more

Survival-inferred fragility of statistical significance in phase III oncology trials

npj Precision Oncology(2025)10.1038/s41698-025-01024-2

N/A

0DataRank · unranked

1 citations

Yufei Liu, Pavlos Msaouel, Timothy A. Lin, Alex Koong, Christine Lin +12 more

Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta‐Epidemiological Analysis

Cancer Medicine(2025)10.1002/cam4.71097

N/A

0DataRank · unranked

1 citations

Pavlos Msaouel, Avital M. Miller, Ramez Kouzy, Timothy A. Lin, Joseph Abi Jaoude +3 more

Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis

European Journal of Cancer(2025)10.1016/j.ejca.2025.115596

N/A

0DataRank · unranked

1 citations

Pavlos Msaouel, Avital M. Miller, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy +7 more

Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials

medRxiv(2025)10.1101/2025.01.11.25320398

N/A

0DataRank · unranked

0 citations

Yufei Liu, Pavlos Msaouel, Timothy A. Lin, Alex Koong, Christine Lin +12 more

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma

BMC Cancer(2020)10.1186/s12885-020-07427-7

N/A

0DataRank · unranked

52 citations

Abdallah Mohamed, Baher Elgohari, Timothy A. Lin, Andrew G. Sikora, Stephen Y. Lai +9 more

Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study

UNC Libraries(2025)10.17615/3115-aq59

N/A

0DataRank · unranked

0 citations

Esther J. Beck, Alexander D. Sherry, Avital M. Miller, Pavlos Msaouel, Ramez Kouzy +8 more

18FDG Positron Emission Tomography Mining for Metabolic Imaging Biomarkers of Radiation-induced Xerostomia in Patients with Oropharyngeal Cancer

medRxiv(2020)10.1101/2020.05.17.20104737

N/A

0DataRank · unranked

7 citations

Carlos Cárdenas, Stefania Volpe, Souptik Barua, Sonja Stieb, Calvin B. Rock +17 more

Tobacco exposure as a major modifier of oncologic outcomes in Human PapillomaVirus (HPV) associated oropharyngeal squamous cell carcinoma

Research Square(2020)10.21203/rs.2.22588/v3

N/A

0DataRank · unranked

0 citations

Abdallah S.R. Mo, Baher Elgohari, Timothy A. Lin, Andrew G. Sikora, Stephen Y. Lai +9 more

Tobacco exposure as a major modifier of oncologic outcomes in Human PapillomaVirus (HPV) associated oropharyngeal squamous cell carcinoma

Research Square(2020)10.21203/rs.2.22588/v4

N/A

0DataRank · unranked

0 citations

Abdallah S.R. Mo, Baher Elgohari, Timothy A. Lin, Andrew G. Sikora, Stephen Y. Lai +9 more

Tobacco exposure as a major modifier of oncologic outcomes in Human PapillomaVirus (HPV) associated oropharyngeal squamous cell carcinoma

Research Square(2020)10.21203/rs.2.22588/v2

N/A

0DataRank · unranked

0 citations

Abdallah S.R. Mo, Baher Elgohari, Timothy A. Lin, Andrew G. Sikora, Stephen Y. Lai +9 more